BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24344235)

  • 21. Tumor-stroma interaction in orthotopic primary pancreatic cancer xenografts during hedgehog pathway inhibition.
    Chang Q; Foltz WD; Chaudary N; Hill RP; Hedley DW
    Int J Cancer; 2013 Jul; 133(1):225-34. PubMed ID: 23280784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, Synthesis and Biological Evaluation of novel Hedgehog Inhibitors for treating Pancreatic Cancer.
    Kumar V; Chaudhary AK; Dong Y; Zhong HA; Mondal G; Lin F; Kumar V; Mahato RI
    Sci Rep; 2017 May; 7(1):1665. PubMed ID: 28490735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sulforaphane regulates the proliferation of leukemia stem-like cells via Sonic Hedgehog signaling pathway.
    Wang F; Huang X; Sun Y; Li Z; Sun R; Zhao T; Wang M; Yan C; Liu P
    Eur J Pharmacol; 2022 Mar; 919():174824. PubMed ID: 35157913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MEDI-573, alone or in combination with mammalian target of rapamycin inhibitors, targets the insulin-like growth factor pathway in sarcomas.
    Zhong H; Fazenbaker C; Breen S; Chen C; Huang J; Morehouse C; Yao Y; Hollingsworth RE
    Mol Cancer Ther; 2014 Nov; 13(11):2662-73. PubMed ID: 25193511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hedgehog signaling and therapeutics in pancreatic cancer.
    Kelleher FC
    Carcinogenesis; 2011 Apr; 32(4):445-51. PubMed ID: 21186299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling.
    Balic A; Sørensen MD; Trabulo SM; Sainz B; Cioffi M; Vieira CR; Miranda-Lorenzo I; Hidalgo M; Kleeff J; Erkan M; Heeschen C
    Mol Cancer Ther; 2014 Jul; 13(7):1758-71. PubMed ID: 24785258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of hedgehog signaling depresses self-renewal of pancreatic cancer stem cells and reverses chemoresistance.
    Huang FT; Zhuan-Sun YX; Zhuang YY; Wei SL; Tang J; Chen WB; Zhang SN
    Int J Oncol; 2012 Nov; 41(5):1707-14. PubMed ID: 22923052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy.
    Yao HP; Feng L; Suthe SR; Chen LH; Weng TH; Hu CY; Jun ES; Wu ZG; Wang WL; Kim SC; Tong XM; Wang MH
    J Immunother Cancer; 2019 Mar; 7(1):75. PubMed ID: 30871619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nicotine induces self-renewal of pancreatic cancer stem cells via neurotransmitter-driven activation of sonic hedgehog signalling.
    Al-Wadei MH; Banerjee J; Al-Wadei HA; Schuller HM
    Eur J Cancer; 2016 Jan; 52():188-96. PubMed ID: 26689865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic and pharmacodynamic modeling of hedgehog inhibitor TAK-441 for the inhibition of Gli1 messenger RNA expression and antitumor efficacy in xenografted tumor model mice.
    Kogame A; Tagawa Y; Shibata S; Tojo H; Miyamoto M; Tohyama K; Kondo T; Prakash S; Shyu WC; Asahi S
    Drug Metab Dispos; 2013 Apr; 41(4):727-34. PubMed ID: 23298863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel hedgehog inhibitor iG2 suppresses tumorigenesis by impairing self-renewal in human bladder cancer.
    Zhu L; Ni C; Dong B; Zhang Y; Shi Y; Niu H; Li C
    Cancer Med; 2016 Sep; 5(9):2579-86. PubMed ID: 27465044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MYB Promotes Desmoplasia in Pancreatic Cancer through Direct Transcriptional Up-regulation and Cooperative Action of Sonic Hedgehog and Adrenomedullin.
    Bhardwaj A; Srivastava SK; Singh S; Tyagi N; Arora S; Carter JE; Khushman M; Singh AP
    J Biol Chem; 2016 Jul; 291(31):16263-70. PubMed ID: 27246849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition.
    Miyazaki Y; Matsubara S; Ding Q; Tsukasa K; Yoshimitsu M; Kosai K; Takao S
    Mol Cancer; 2016 Jun; 15(1):49. PubMed ID: 27349387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype.
    Schultz MJ; Holdbrooks AT; Chakraborty A; Grizzle WE; Landen CN; Buchsbaum DJ; Conner MG; Arend RC; Yoon KJ; Klug CA; Bullard DC; Kesterson RA; Oliver PG; O'Connor AK; Yoder BK; Bellis SL
    Cancer Res; 2016 Jul; 76(13):3978-88. PubMed ID: 27216178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
    Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H
    J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reprogramming Medulloblastoma-Propagating Cells by a Combined Antagonism of Sonic Hedgehog and CXCR4.
    Ward SA; Warrington NM; Taylor S; Kfoury N; Luo J; Rubin JB
    Cancer Res; 2017 Mar; 77(6):1416-1426. PubMed ID: 28031228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor Inhibitory Effect of IRCR201, a Novel Cross-Reactive c-Met Antibody Targeting the PSI Domain.
    Park H; Kim D; Kim E; Sa JK; Lee HW; Yu S; Oh J; Kim SH; Yoon Y; Nam DH
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gedunin inhibits pancreatic cancer by altering sonic hedgehog signaling pathway.
    Subramani R; Gonzalez E; Nandy SB; Arumugam A; Camacho F; Medel J; Alabi D; Lakshmanaswamy R
    Oncotarget; 2017 Feb; 8(7):10891-10904. PubMed ID: 26988754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GALNT1-Mediated Glycosylation and Activation of Sonic Hedgehog Signaling Maintains the Self-Renewal and Tumor-Initiating Capacity of Bladder Cancer Stem Cells.
    Li C; Du Y; Yang Z; He L; Wang Y; Hao L; Ding M; Yan R; Wang J; Fan Z
    Cancer Res; 2016 Mar; 76(5):1273-83. PubMed ID: 26676748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma.
    Singh AR; Joshi S; Zulcic M; Alcaraz M; Garlich JR; Morales GA; Cho YJ; Bao L; Levy ML; Newbury R; Malicki D; Messer K; Crawford J; Durden DL
    PLoS One; 2016; 11(3):e0150836. PubMed ID: 26938241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.